AI assistant
Hansa Biopharma Director's Dealing 2023
3057_iss_2023-08-16_e595b18d-a6b9-4e0d-ae32-3905a8f06c4f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Issuer Hansa Biopharma AB
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
Instrument
| Instrument | Aktier |
|---|---|
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Date | 15/08/2023 |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,753,873 |
| Directly held voting rights 0 | |
| Indirectly held voting rights 1,753,873 | |
| Percentage | |
| Directly held shares | 3.18688 % |
| Directly held voting rights 0 % | |
|---|---|
| Indirectly held voting rights 3.31495 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 3.31495 % | 1,753,873 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
1.68716 % | 892,642 |
| Total | 5.00211 % | 2,646,515 |
Group total holdings
Voting rights 2,646,515
Percentage of voting rights 5.00211
Notes (other relevant informations according to law)
Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet. Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt förvärvat de aktuella värdepapperna.
Published
16/08/2023 13:10
Contact
Name Joakim Lomell
Email [email protected]
*Source of information has chosen not to submit the data
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25